These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 2084948

  • 1. Comparative antithrombotic and hemorrhagic effects of dermatan sulfate, heparan sulfate and heparin.
    Hoppensteadt D, Walenga JM, Fareed J.
    Thromb Res; 1990 Nov 01; 60(3):191-200. PubMed ID: 2084948
    [Abstract] [Full Text] [Related]

  • 2. Comparative antithrombotic and hemorrhagic effects of dermatan sulfate, heparan sulfate, and heparin.
    Hoppensteadt D, Racanelli A, Walenga JM, Fareed J.
    Semin Thromb Hemost; 1989 Oct 01; 15(4):378-85. PubMed ID: 2530633
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of dermatan sulfate and heparan sulfate on platelet activity compared to heparin.
    Hoppensteadt DA, Walenga JM, Fareed J.
    Semin Thromb Hemost; 1991 Oct 01; 17 Suppl 1():60-4. PubMed ID: 2068572
    [Abstract] [Full Text] [Related]

  • 5. A comparison of the activity of a heparan sulphate of defined molecular weight range (7500-15,000 Da) with heparin and dermatan sulphate.
    Gervasi GB, Catalani R, Bartoli C, Carpita G, Farina C, Gelso E.
    Pharmacol Res; 1995 Jun 01; 31(6):331-6. PubMed ID: 8685069
    [Abstract] [Full Text] [Related]

  • 6. The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin.
    Buchanan MR, Boneu B, Ofosu F, Hirsh J.
    Blood; 1985 Jan 01; 65(1):198-201. PubMed ID: 3965047
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects on platelets and on the clotting system of four glycosaminoglycans extracted from hog mucosa and one extracted from aortic intima of the calf.
    Cella G, Scattolo N, Luzzatto G, Stevanato F, Vio C, Girolami A.
    J Med; 1986 Jan 01; 17(5-6):331-46. PubMed ID: 2953835
    [Abstract] [Full Text] [Related]

  • 9. Low affinity heparin is an antithrombotic agent.
    Gray E, Cesmeli S, Lormeau JC, Davies AB, Lane DA.
    Thromb Haemost; 1994 Feb 01; 71(2):203-7. PubMed ID: 8191399
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways.
    Ofosu FA, Modi GJ, Smith LM, Cerskus AL, Hirsh J, Blajchman MA.
    Blood; 1984 Sep 01; 64(3):742-7. PubMed ID: 6235872
    [Abstract] [Full Text] [Related]

  • 12. Increased sulphation improves the anticoagulant activities of heparan sulphate and dermatan sulphate.
    Ofosu FA, Modi GJ, Blajchman MA, Buchanan MR, Johnson EA.
    Biochem J; 1987 Dec 15; 248(3):889-96. PubMed ID: 2963622
    [Abstract] [Full Text] [Related]

  • 13. Lipoprotein-associated coagulation inhibitor (LACI) is a cofactor for heparin: synergistic anticoagulant action between LACI and sulfated polysaccharides.
    Wun TC.
    Blood; 1992 Jan 15; 79(2):430-8. PubMed ID: 1346095
    [Abstract] [Full Text] [Related]

  • 14. Effects of heparin, dermatan sulfate and of their association on the inhibition of venous thrombosis growth in the rabbit.
    Carrie D, Caranobe C, Gabaig AM, Larroche M, Boneu B.
    Thromb Haemost; 1992 Dec 07; 68(6):637-41. PubMed ID: 1287877
    [Abstract] [Full Text] [Related]

  • 15. Experimental studies on the relative efficacy of dermatan sulphate and heparin as antithrombotic agents.
    Merton RE, Thomas DP.
    Thromb Haemost; 1987 Oct 28; 58(3):839-42. PubMed ID: 3433248
    [Abstract] [Full Text] [Related]

  • 16. A randomized blind study comparing standard heparin and a new low molecular weight heparinoid in cardiopulmonary bypass surgery in dogs.
    Henny CP, Ten Cate H, Ten Cate JW, Moulijn AC, Sie TH, Warren P, Büller HR.
    J Lab Clin Med; 1985 Aug 28; 106(2):187-96. PubMed ID: 4020247
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Development of new heparin-like compounds and other antithrombotic drugs and their interaction with vascular endothelial cells.
    Nader HB, Pinhal MA, Baú EC, Castro RA, Medeiros GF, Chavante SF, Leite EL, Trindade ES, Shinjo SK, Rocha HA, Tersariol IL, Mendes A, Dietrich CP.
    Braz J Med Biol Res; 2001 Jun 28; 34(6):699-709. PubMed ID: 11378657
    [Abstract] [Full Text] [Related]

  • 19. The anticoagulant effect of heparan sulfate and dermatan sulfate.
    Teien AN, Abildgaard U, Höök M.
    Thromb Res; 1976 Jun 28; 8(6):859-67. PubMed ID: 134464
    [No Abstract] [Full Text] [Related]

  • 20. Orgaran (Org 10172): its pharmacological profile in experimental models.
    Meuleman DG.
    Haemostasis; 1992 Jun 28; 22(2):58-65. PubMed ID: 1379965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.